2021 -2023 Executive Director, Head of Alliance Management @
2021 -2021 Senior Director, Alliance Management @
2016 -2021 Director, Global Alliance Management @
2011 -2016 Senior Principal Scientist, Neuroimmunology Research @
2009 -2011 Principal Scientist, Oncology Research @
2003 -2009 Senior Scientist, Oncology Research @
2000 -2003 Staff Scientist Level II, Gene Expression and Analysis Group @
1997 -2000 Staff Scientist Level I and Head of Positional Cloning Group @
1994 -1997 Postdoctoral Fellow @
Sharon Morgenbesser Education
Albert Einstein College of Medicine
Sharon Morgenbesser Skills
Relationship Development
Negotiation
Multitasking
Leadership
Conflict Resolution
Collaboration Solutions
Hematology
Rare Blood Disorders
Greater China
China Business Development
Due Diligence
Search and Evaluation
External Innovation
Life Sciences
Medical Devices
Contractual Agreements
Contract Negotiation
Contract Management
Cross-functional Team Leadership
Strategic Planning
Cell Based Assays
Clinical Development
Clinical Trials
Vaccines
Rare Diseases
Allergy
Infectious Diseases
Digital Therapeutics
Neuroscience
Neurology
Ophthalmology
Partner Relationship Management
Strategic Partnerships
Multiple Sclerosis
Pre-clinical Studies
Cancer Biology
Cancer Research
Oncology
People Management
Biotechnology Industry
Global Alliance Management
Strategic Alliances
Drug Development
Molecular Immunology
Technology
Research
Education
Sharon Morgenbesser Summary
Sharon Morgenbesser, based in Boston, MA, US, is currently a Director, Alliance Management for Genetic Medicines at Alloy Therapeutics, Inc.. Sharon Morgenbesser brings experience from previous roles at Freelance, Fulcrum Therapeutics and AffaMed Therapeutics. Sharon Morgenbesser holds a Albert Einstein College of Medicine. With a robust skill set that includes Relationship Development, Negotiation, Multitasking, Leadership, Conflict Resolution and more. Sharon Morgenbesser has 2 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Sharon Morgenbesser?
Find contact details for 700 million professionals.